1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > South Korea Proton Therapy Outlook 2020

South Korea Proton Therapy Outlook 2020

  • November 2015
  • -
  • RNCOS
  • -
  • 50 pages

With an increasing incidence of cancer in South Korea, there is a definite need for novel, cutting edge, treatment methods. Once such technique is the Proton Therapy, which is one of the most advanced radiation technique available today. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients.

According to the “South Korea Proton Therapy Outlook 2020” report by RNCOS, by 2020, South Korea will have two proton therapy centers. Consequently, the market will attain revenue of around US$ 15.3 Million by 2020, growing at a CAGR of 24.4% during the forecast period (2014-2020). The report also provides an insight into the cancer demographics of South Korea, and the various possible causes for a high cancer incidence in the country.

Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country, etc., the report provides potential proton therapy market in South Korea. The report also includes the current and future demands for the number of proton therapy centers in the country. Furthermore, analysis of the current and upcoming proton therapy centers, along with an estimation of the shortage of proton centers in the current and future scenario is also provided in the report.

The report also provides an insight of the drivers and challenges, which would have a major influence in shaping the growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2020. There is also a ‘strengths-weakness’ analysis of equipment vendors along with their business overview, products & services, and existing & planned installations in US till 2020, thus making it a must read for consultants and companies planning to enter the market.

Table Of Contents

South Korea Proton Therapy Outlook 2020
1. Analyst View
2. Research Methodology
3. South Korea Cancer Demographics
3.1 Incidence by Site
4. Current Radiation Therapies
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Proton Therapy
4.6.1 Need for Proton Therapy
5. Components of a Standard Proton Therapy Center
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource
6. South Korea Proton Therapy Market
6.1 Current Market Size and Future Growth
6.2 Potential Patients
6.2.1 Market Penetration
6.3 Opportunity Assessment
6.4 Proton Therapy Centers Analysis
7. Market Dynamics
7.1 Drivers
7.1.1 Increasing Incidence of Cancer
7.1.2 Medical Tourism in South Korea
7.1.3 Benefits over Conventional Therapies
7.2 Restraints
7.2.1 High Cost of treatment
8. Competitive Landscape and Strategic Analysis
8.1 IBA
8.2 Sumitomo Heavy Industries, Ltd.

List of Figures:

Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: South Korea - Proton Therapy Market (Million US$), 2014-2020
Figure 6-2: Share of Proton Therapy Market in Potential Market (%), 2015
Figure 6-3: Share of Proton Therapy Market in Potential Market (%), 2020
Figure 6-4: Demand of Proton Therapy Centers (2015 and 2020)
Figure 6-5: Shortage of Proton Therapy Centers (2015 and 2020)
Figure 6-6: Patients treated with Proton Therapy at NCC, Korea (2007-2014)
Figure 7-1: Cancer Incidence (‘000), 2012-2015, 2025 and 2035
Figure 8-1: IBA - Breakdown of Revenue by Activity (%), 2014

List of Tables:

Table 3-1: Cancer Incidence Growth by Site (2015 to 2035)
Table 5-1: Human Resource Requirements and their role in Proton Therapy Center
Table 6-1: South Korea - Potential Patients for Proton Therapy (2015 and 2020)
Table 8-1: IBA - Proton Therapy Products and Services
Table 8-2: IBA - Key Financials (Million US$), 2012-2014
Table 8-3: IBA - Proton Therapy Installations in South Korea
Table 8-4: IBA - Strengths and Weaknesses
Table 8-5: Sumitomo - Key Financials (US$ Million), 2012-2014
Table 8-6: Sumitomo - Proton Therapy Installations in South Korea
Table 8-7: Sumitomo - Strengths and Weaknesses

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • January 2017
    19 pages
  • Therapy  

  • United Kingdom  

View report >

Biological Therapy Industry in the US

  • January 2017
    9 pages
  • Vaccine  

  • United States  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.